Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
- 1 March 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (5), 1380-1385
- https://doi.org/10.1016/j.bmcl.2009.01.045
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary DiseaseJournal of Medicinal Chemistry, 2008
- Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Novel 5,6-dihydropyrazolo-[3,4-E][1,4]diazepin-4 (1H)-one derivatives for the treatment of asthma and chronic obstructive pulmonary diseaseExpert Opinion on Therapeutic Patents, 2007
- Sleep-related breathing disorders: impact on mortality of cerebrovascular diseaseEuropean Respiratory Journal, 2004
- New therapies for chronic obstructive pulmonary diseaseExpert Opinion on Investigational Drugs, 2004
- Synthesis and evaluation of quinoline carboxyguanidines as antidiabetic agentsBioorganic & Medicinal Chemistry Letters, 2000
- Transition metal mediated thiation of aromatic ringsTetrahedron, 1991
- A novel synthesis of 4-[alkyl(aryl)sulfonyl]benzaldehydes: alkyl(aryl)sulfinate anion as a nucleophile in aromatic substitutionsThe Journal of Organic Chemistry, 1989
- The reactions of an N-sulfonylamine inner saltJournal of the American Chemical Society, 1968
- The Synthesis of Certain Substituted Quinolines and 5,6-BenzoquinolinesJournal of the American Chemical Society, 1939